Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.5.3 to v3.5.4, representing a small version bump. This change does not modify visible content or behavior.
    Difference
    0.0%
    Check dated 2026-05-15T16:23:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed site revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor backend or UI release rather than a change to the trial record content.
    Difference
    0.0%
    Check dated 2026-04-24T06:24:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:53:23.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:59:01.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T00:00:41.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice (Revision: v3.4.1) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:20:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.